Moderna’s COVID shots are hard to justify the price hike

WASHINGTON (Reuters] – It is difficult to justify the price increase for Moderna Inc COVID-19 shot, a spokesperson for the White House Karine Jean Pierre said Thursday.

Moderna may price its vaccine in the United States at $110-$130 per dose, according to Stephane Bancel (CEO), who spoke to the Wall Street Journal Monday.

(Reporting by Jeff Mason and Jarrett Renshaw. Editing by Leslie Adler.